IMMUNE STUDIES IN HOMOSEXUAL MEN AT RISK FOR ACQUIRED IMMUNE DEFICIENCY SYNDROME
对有获得性免疫缺陷综合症风险的男同性恋者进行免疫研究
基本信息
- 批准号:3962956
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AIDS T lymphocyte antiAIDS agent cellular pathology disease /disorder proneness /risk helper T lymphocyte homosexuals human immunodeficiency virus 1 immunopathology interferons leukocytes male microorganism immunology neoplasm /cancer genetics neoplasm /cancer immunology suppressor T lymphocyte thymosin tissue /cell culture virus classification
项目摘要
Peripheral blood leukocytes (PBL) from HTLV-III antibody (+) and (-) donors
were tested for proliferative (3H) and cell-mediated lympholysis (CML) to
influenza virus (S+X) and to HLA allogeneic cells (ALLO). Among antibody
(+) donors, approximately 50% failed to respond to S+X, whereas all
responded to ALLO, except patients in the critical stages of AIDS, who
responded to neither type of immunogen.
Using PBL from antibody (-) donors we demonstrated by cell fractionation
techniques that S+X T cell responses are obliged to use CD4+ T cells,
whereas ALLO responses can be generated by either CD4+ or CD4- T cells.
Thus, the selective loss of S+X responses probably reflects the loss of
CD4+ cells during AIDS development.
Using the above approach, we have tested T cell functions in AIDS patients
undergoing therapy with the thymidine analog AZT. Some patients undergoing
AZT exhibited a restoration of T cell immune function.
PBL from antibody (-) donors were infected with HTLV-III after stimulation
with PHA or HLA alloantigens. PHA stimulated cells produced virus early
but the cultures died within 2 weeks. In contrast, alloantigen stimulated
cultures survived and produced virus for at least 40 days.
HTLV-III抗体(+)和(-)供者外周血白细胞(PBL)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
G M SHEARER其他文献
G M SHEARER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('G M SHEARER', 18)}}的其他基金
CELL MEDIATED IMMUNITY TO HAPTEN MODIFIED SYNGENEIC LYMPHOCYTES IN MICE
小鼠中针对半抗原修饰的同源淋巴细胞的细胞介导的免疫
- 批准号:
4691755 - 财政年份:
- 资助金额:
-- - 项目类别:
DETECTION AND ANALYSIS OF H-2 VARIANT CELL LINES FROM MURINE T CELL LYMPHOMAS
鼠 T 细胞淋巴瘤 H-2 变异细胞系的检测和分析
- 批准号:
4691769 - 财政年份:
- 资助金额:
-- - 项目类别:
SYNERGISTIC EFFECTS OF MURINE CYTOMEGALOVIRUS AND GRAFT-VERSUS-HOST REACTION
鼠巨细胞病毒与移植物抗宿主反应的协同效应
- 批准号:
3962949 - 财政年份:
- 资助金额:
-- - 项目类别:
IMMUNE STUDIES IN HOMOSEXUAL MEN AT RISK FOR ACQUIRED IMMUNE DEFICIENCY SYNDROME
对有获得性免疫缺陷综合症风险的男同性恋者进行免疫研究
- 批准号:
3939243 - 财政年份:
- 资助金额:
-- - 项目类别:
SYNERGISTIC EFFECTS OF MURINE CYTOMEGALOVIRUS AND GRAFT-VERSUS-HOST REACTION
鼠巨细胞病毒与移植物抗宿主反应的协同效应
- 批准号:
3916407 - 财政年份:
- 资助金额:
-- - 项目类别:
EFFECTS OF GRAFT VS HOST REACTIONS ON CELL-MEDIATED IMMUNITY
移植物抗宿主反应对细胞介导免疫的影响
- 批准号:
3813460 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual